Amgen Inc. - Common Stock

$186.73 +$4.28 +2.29%

Own 1 of AMGN at $183.59 which is 0.23% of the portfolio.

+$3.14 (+1.71%)

Shares Bought2
Shares Sold1
Shares Owned1
Last Price$186.73
Total Return$4.37
Range Today$182.77 - $186.77
52 Week Range$152.16 - $201.23
Market Cap$134.81B
P/E Ratio72.64

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. Its products include aranesp, blincyto, corlanor, enbrel, epogen, imlygic, kyprolis, neulasta, neupogen, nplate, parsab, prolia, repatha, sensipar, vectibix, and xgeva. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Wallet Positions

Buy Date Buy Price Quote Return $ Return % Owners

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
18-02-20 19:29 $183.59 $186.73 +$3.14 +1.71% mpcortes

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-06-08 15:37 17-06-15 20:48 $162.86 $164.09 +$1.23 +0.76% alb_mysatellite flall radiatoren maken13 esox2112 6cbestegymbsb blu3m4n thecoolguy690 a_i_d_e_n nord_vietnam